Free shipping

Lasercombs for Female Pattern Hair Loss: What the 2014 Trials Measured

An evidence check of the female trial results, their limits and questions to bring before buying a device.

Adult woman in a pink sweater reviewing a blank notebook beside a closed laptop at home.
In this article
  1. Who and what were studied?
  2. What did the hair counts show?
  3. Did participants report fuller hair?
  4. Where are the limits?

If a laser hair device is on your shopping list, take the study behind its claims to your dermatologist. You may be hoping to see less scalp in your part, but want to understand what the research actually measured before committing money and time.

Who and what were studied?

Two randomized, double-blind female trials compared nine- or twelve-beam lasercombs with sham devices for 26 weeks. Of 141 women randomized, 122 had a follow-up evaluation and entered the efficacy analysis; 19 were lost to follow-up.1

Ask whether the device you are considering is the one studied. Bring the exact model and the research link, rather than relying on a product-category name.

What did the hair counts show?

In the measured scalp area, average terminal-hair density rose by 20.2 hairs/cm² with the nine-beam device versus 2.8 with sham, and 20.6 versus 3.0 in the twelve-beam trial. Both differences were statistically significant.1

Ask your dermatologist what an appropriate outcome would look like in your case and how you would record it. Discuss the practical cost and use instructions alongside that proposed outcome.

Did participants report fuller hair?

Self-reported improvement in hair-loss condition and thickness/fullness reached statistical significance in the nine-beam female trial, but not the twelve-beam trial. The study’s measured density result and participants’ assessments were not identical findings.1

Tell the dermatologist which change matters to you. Ask how that concern would be reviewed if you and the clinician decide to try a device.

Where are the limits?

The study excluded several other scalp or hair-loss conditions and pregnancy. Participants had Fitzpatrick skin types I–IV; the female groups were mostly White. Follow-up ended at 26 weeks, so this report does not establish long-term maintenance or results for every hair-loss diagnosis.1

The manufacturer partly funded the study and supplied devices and imaging equipment. Some authors disclosed manufacturer fees or study funding.1

Have the dermatologist explain how the evidence applies to your diagnosis and the model being offered. Ask for the review date, what would justify continuing and whom to contact about problems. Keep that discussion with your existing treatment instructions before making changes.

Hair, Everywhere includes a monthly Hair Log and visit script. Use them to organize questions and agreed observations alongside your dermatologist’s assessment.

This article is for general educational purposes only and is not medical advice. It isn't a substitute for diagnosis or treatment from a qualified healthcare professional who knows your health history. Please don't ignore professional advice or delay getting care because of something you read here. If you think you may be having a medical emergency, call 911 or your local emergency number right away. Girl Playbook does not endorse any specific product, test, or provider.

Read our health disclaimer

Girl Playbook sells this book. It provides education and worksheets, not individualized medical care.

Sources

The research behind this article, in the order it’s cited. How we source our articles.

  1. American Journal of Clinical Dermatology, 2014Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study (opens in a new tab)abcde

Spotted something out of date? Tell us and we’ll check it.

Private questions deserve good answers.

Ten Playbooks, one for each of the problems women rarely talk about.

Shop the Playbooks